First human test of new obesity injection begins
NCT ID NCT06737536
Summary
This study tested the safety of a new injectable medication called NNC0662-0419 for people with overweight or obesity. It was the first time this experimental drug was given to humans. Researchers monitored 100 participants for about 9 months to see how their bodies handled the medicine and to check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion, Lincoln
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.